Navigation Links
Israeli Innovation Shown to Demonstrate Reduction in Headaches and Neck Pain
Date:11/26/2012

TEL AVIV, Israel, November 26, 2012 /PRNewswire/ --

Israel-based medical device company  Headway medical  reports the successful completion of a series of clinical trials of Occiflex, its innovative therapeutic table designed to reduce chronic neck pain and headaches. The device will be available, starting in 2013, to physiotherapy clinics and rehabilitation centers throughout the world.

A revolutionary new device based on the principles of physiotherapy, Occiflex supports slow, repeated, and precise treatment for patients with muscle-dysfunction-related chronic pain. The Occiflex table mechanism allows physiotherapists to devise a manual mobilization file that is tailored to the needs of each patient, and, since it does not depend on the therapist's physical abilities, it can continue therapy for much longer than is standard and possible today. Plus, since each patient's therapy protocol is saved in a database, treatment can be reproduced precisely each time. The patient's file can be modified at any time, as conditions changes. The Occiflex treatment table improves the condition of the cervical joints, muscle, ligaments, and central nervous system control over the neck and head.

The Clinical Journal of Pain recently published a scientific article that describes the clinical trial conducted by Headway in the physiotherapy department of the Bnei Zion Medical Center in Haifa, Israel. The trial tested the advanced prototype developed by the company. Results indeed demonstrated a reduction of chronic neck pain in the patients and increased mobility.

According to Tamir Levital, CEO of Headway, "Occiflex will make the work of 50,000 physiotherapy and pain centers around the world more efficient and provide relief for the hundreds of millions who suffer from chronic neck pain and headaches. It will also save physiotherapists time and energy, and permit them to treat a number of patients simultaneously. The results of our trials show that Occiflex permits more precise, effective, repeated, and longer treatment than is possible today. We are very happy with the results of the trial and are getting ready to market Occiflex starting in 2013."

Headway, which got its start in the Misgav Venture Accelerator (owned by the Trendlines Group), was founded in 2006 by Dr. Yaron River, chief physician at the Neurology Department, Hillel Yaffe Medical Center, Hadera. The company has raised $1.5 million from private investors, the Misgav Venture Accelerator, and government R&D grants.

Media relations:
Efrat Kaduri
Ofir Shpigel Media and Public Relations
+972-4-9535030


'/>"/>
SOURCE Headway Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Fujifilm Spotlights DR Expansion, Innovation At RSNA 2012
2. Jury for 2012 Intercultural Innovation Award Announced
3. Le Dr Beau Lotto se joint aux grands penseurs à loccasion du débat sur linnovation 2012
4. Le professeur Brian Cox se joint aux grands penseurs à loccasion du débat sur linnovation 2012
5. Cutting-Edge German Medical Innovations Put Patients First
6. El profesor Brian Cox se une a los grandes pensadores en The Innovation Debate 2012
7. El doctor Beau Lotto se une a los grandes pensadores en The Innovation Debate 2012
8. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
9. CardioMEMS Named as a Finalist for Intel Innovation Award
10. Innovations in Ophthalmic Devices - Anterior Segment
11. Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):